WIN-x Synthetic Cannabinoids Cannabinoid Research

WIN-x Synthetic Cannabinoids Research Dashboard

Loading research dashboard…

Loading Primary Studies…

Loading Related Studies…

Overview - WIN-x Synthetic Cannabinoids

Description of WIN-x Synthetic Cannabinoids

WIN 55,212-2 is the most studied compound in the WIN-x group of synthetic cannabinoids. Other members that show up the CK primary study list include WIN 55-940 (full agonist at CB1 and CB2).


Here we focus on WIN 55,212-2.

Other Names:

WIN Family Synthetic Cannabinoids

WIN 55,212-2; WIN 55212-2; Win-55212-2; Win 55,212 plus numerous other supplier-based synonyms.


IUPAC name: [(11R)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone


Molecular Formula: C27H26N2O3


Source–PubChem

WIN-x Synthetic Cannabinoids Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

WIN-x Synthetic Cannabinoids Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.